Reports: FDA expected to OK ‘mix-and-match’ COVID vaccine boosters

The Food and Drug Administration (FDA) is expected to announce this week people will be able to receive a COVID-19 vaccine booster shot with a vaccine from a different manufacturer than their original doses, according to reports in the New York Times, Washington Post and Wall Street Journal.

The Food and Drug Administration (FDA) is expected to announce this week people will be able to receive a COVID-19 vaccine booster shot with a vaccine from a different manufacturer than their original doses, according to reports in the New York Times, Washington Post and Wall Street Journal.

That would mean someone who received doses of a Moderna COVID-19 vaccine would be allowed to receive a Pfizer COVID-19 vaccine booster shot, or the other way around. The Washington Post reported that this “mix-and-match” decision from the FDA will be part of its authorization for the Moderna and Johnson & Johnson vaccines. That decision is expected this week.

Pfizer’s booster shots started in September for vulnerable Americans.

The Times was first to report the “mix-and-match” announcement, stating the FDA wasn’t expected to push for one vaccine over another but that it might recommend people stay with their original vaccine, if possible.


COVID-19 Discussion Forum:

Join our dedicated space to discuss the pandemic. You’re invited to share questions, experiences, insights and opinions.

Join the conversation here.


About the Author:

Dave Bartkowiak Jr. is the digital managing editor for ClickOnDetroit.